How have BELL shares performed this year?

Belluscura's stock was trading at GBX 23 at the start of the year. Since then, BELL shares have decreased by 47.8% and is now trading at GBX 12. View the best growth stocks for 2024 here .

How do I buy shares of Belluscura?

Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:BELL

Belluscura (BELL) Share Price, News & Analysis

GBX 12

0.00 (0.00%)

(As of 09/17/2024 ET)

Compare

Get Belluscura alerts:

About Belluscura Stock (LON:BELL)

Advanced Chart

Get Belluscura alerts:

Key Stats

Today's Range: 11
▼
13
50-Day Range: 10
▼
15
52-Week Range: 7
▼
43
Volume: 20,803 shs
Average Volume: 296,556 shs
Market Capitalization: £20.21 million
P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A
Consensus Rating: N/A

Company Overview

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

BELL Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BELL Stock Analysis - Frequently Asked Questions

: Belluscura's stock was trading at GBX 23 at the start of the year. Since then, BELL shares have decreased by 47.8% and is now trading at GBX 12.
View the best growth stocks for 2024 here.
: Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: LON:BELL
CUSIP: N/A
CIK: N/A
Web: www.belluscura.com
Phone: N/A
Fax: N/A
Employees: 24
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.11)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 11.23
P/E Growth: N/A
Net Income: £-18,520,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -97.35%
Return on Assets: -48.17%

Debt

Debt-to-Equity Ratio: 1.16
Current Ratio: 2.79
Quick Ratio: 5.13

Sales & Book Value

Annual Sales: £1.20 million
Price / Sales: 18.24
Cash Flow: GBX 1.63 per share
Price / Cash Flow: 8.00
Book Value: GBX 13 per share
Price / Book: 1.00

Miscellaneous

Outstanding Shares: 168,410,000
Free Float: N/A
Market Cap: £21.89 million
Optionable: Not Optionable
Beta: 1.05

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (LON:BELL) was last updated on 9/17/2024 by MarketBeat.com Staff

From Our Partners